News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Acetylon Pharmaceuticals Raises $12.4 Million



2/23/2011 7:02:46 AM

Xconomy -- Acetylon Pharmaceuticals, a developer of drugs that inhibit HDAC enzymes to treat cancer and autoimmune diseases, has raised $12.4 million of a proposed $30 million second round of equity financing, according to an SEC filing.

Read at Xconomy


comments powered by Disqus
Xconomy
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES